 Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores
Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore
Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores
LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26
Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26 Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores
Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores 
              The Board of Directors of Krebs Biochemicals & Industries Ltd at its meeting held on Monday, 25th March 2019 has approved the allotment of 28,86,300 equity shares as per the basis of allotment approved by BSE Limited (the Designated Stock Exchange) on 22nd March 2019. Further, the paid-up equity share capital of the Company amounts to Rs. 16,63,05,860/- divided into 1,66,30,586 equity shares of Rs. 10/- each.
Shares of KREBS BIOCHEMICALS & INDUSTRIES LTD. was last trading in BSE at Rs.93.25 as compared to the previous close of Rs. 94.4. The total number of shares traded during the day was 526 in over 10 trades.
The stock hit an intraday high of Rs. 96.5 and intraday low of 93. The net turnover during the day was Rs. 49581.